Barry E. Greene - 05 Aug 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
President and CEO, Director
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Barry Greene
Issuer symbol
SAGE
Transactions as of
05 Aug 2021
Net transactions value
+$1,020,054
Form type
4
Filing time
09 Aug 2021, 09:07:53 UTC
Previous filing
17 Jun 2021
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Purchase $1,020,054 +23,640 +269% $43.15 32,440 05 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $42.66 USD to $43.46 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.